Critical Care 2017-04-04T08:34:58+00:00

The Ultrasonic Nebuliser InfraControl can be used with all respirators.

The device must be installed into your respiration system only as described in the instruction manual.

After switching on the ultrasonic nebuliser InfraControl the aerosol is produced permanently.

Also after pulmonary thrombosis-erte-riectomy (PEA) persistent or temporary pulmonary blood pressure valves can occur as a therapeutic problem.

Also patients with chronic forms of the pulmonary hypertension (for example PAH) can need an intensive-medical treatment due to an increasing or acute right-heart-decomposition.

If it is delivered through the inspiratory thigh of the respirator to the patient or is delivered via the inspiratory parallel tube respectively through the control tube for mechanical nebulisationonly during the inspiration stage directly to the T-joint of the tube. After the medicine has been used up, the ultrasonic nebuliser InfraControl switches itself automatically off.

With patient’s recieving critical care therapy and treatment for pulmonary hypertension often occurs for which there are different causes. A postoperative persistence or increase of the pulmonary-arterial pressure valves appears frequently after surgical procedures at the heart and after heart transplantation, which means operations with a heart pulmonary machine!

Also after pulmonary thrombosis erte riectomy (PEA) persistent or temporary pulmonary blood pressure values can occur as a therapeutic problem. Also patients with chronic forms of the pulmonary hypertension (for example PAH) can need an intensive-medical treatment due to an increasing or acute right-heart-decomposition.

A pulmonary hypertension can be based on very different basic diseases in the child and newborn age. Causes are mainly the persisting pulmonary hypertension of the newborn (PPHN), the broncho-pulmonary (BPD), the pulmonary hypertension with innate cardiac defects, the genuine pulmonary hypertension (iPAH) or also the hypoxic pulmonary failure.

Several cases and studies with a small number of patients indicate a potential benefit for pulmonary hypertension blood pressure lowering through inhaled Iloprost in cardio-surgical post-operative use. The circuit configurations allowed stabilisation by the selective effect on the pulmonary heamodynamics, reduced partially the respiration time and supported in total complication-free postoperative process.

Iloprost is evaluated as a good alternative to the administration of nitrogen. Compared to concise pulmonary vasodilation with nitrogen good compatibility and simple handling are emphasized by inhaled Iloprost.

Also clinically unstable high risk patients with PAH can benefit from an inhaled Iloprost dose according to published study results.

BENEFITS OF USE:- Usable with all respirators

  • – Declarations of compatibility for different nebulisers available
  • – Easy and Noiseless operation
  • – Effective and easy realizable cleaning
  • – Automatic shutdown after use of medication
  • – Reduced consumption material through direct nebulising
  • – Unsurpassed price / performance ratio